The health, safety and well-being of our members, staff, exhibitors, faculty, patients and other stakeholders remain of paramount importance. With continued uncertainty surrounding the COVID-19 pandemic and travel advisories and restrictions still in place in the U.S. and globally, the College hopes the new dates will allow more people to attend ACC.21 in person. The exciting live program will provide unique opportunities to reimagine global heart health, refocus on science, and reconnect with colleagues from around the world.
Frequently Asked Questions
Major meetings are years in the making so finding new dates on short notice poses many challenges. ACC was fortunate to be offered dates in May that became available.
While we hope more people can and will attend ACC.21 in person, we also understand that some members may have personal and/or professional conflicts in addition to ongoing concerns about COVID-19 safety. As a result, the ACC is absolutely committed to developing a robust ACC.21 Virtual program with on demand options that will ensure that members from around the world can participate and engage with the meeting at times and in ways that work for individual schedules. Look for more details on both options on the ACC Scientific Session website this fall. If you can't make it to ACC.21 in person, we look forward to seeing you in Washington, DC, for ACC.22.
Registration for both ACC.21 and ACC.21 Virtual will open in October. Look for announcements and more details in the coming weeks.
In addition, faculty invitations will also be sent in October to coordinate with the opening of registration.
The ACC.21 Abstract/Case Submission site will open in October. Submissions for LBCTs will open in early December. Look for more details on the submission process and deadlines on the in the coming weeks.
Requests for exceptions to these eligibility requirements must be made in writing and will be reviewed by the ACC.21 Chair and ACC.21 Vice Chair. These situations are expected to be rare given the comprehensive guidance as detailed above.
If you have any questions, please contact Holly Santry on ACC staff at (email@example.com).
If it is accepted for publication close to the ACC.21 dates, it is possible to coordinate the date of publication with the ACC Media Relations team and the respective journal so that the ACC.21 embargo policies are not violated.
1) Fellow in Training (FIT): The first author is a medical student or anyone in a fellowship or residency program. The presenter must be a Fellow in Training (FIT).
2) Cardiovascular Team: The first author must be a non-physician CV team member, which could include nurses, advanced practice nurses, pharmacists, physician assistants, CV practice administrators, technologists, registered dietitian nutritionists or exercise specialists/physiologists. The presenter must be a CVT member.
3) MD/PhD: The first author is a medical doctor or researcher. The presenter is a medical doctor or researcher.
Priority will be given to FIT and Cardiovascular Team submissions during the selection process.
| 2020 American College of Cardiology Foundation. Visit ACC.org|